Yi Li
Directeur/Membre du Conseil chez Shanghai Bioveda Investment Management Consulting Co. Ltd.
Profil
Dr. Yi (Robert) Li, PhD, partner, has over fifteen years of Life Sciences experience in venture investment and management, R&D, and corporate development in the China and the U.S.
Prior to joining BioVeda China, Dr. Li was Vice President of Sinogen International, Ltd., (Shanghai, Hong Kong and Shenzhen, China), a biotechnology investment holding company of H&Q Asia Pacific, a venture capital firm with US$1.8 billion under management.
Dr. Li spent nine years with Sinogen during which he evaluated biotech investment opportunities and corporate collaborations throughout China, as well as, the U.S.Prior to Sinogen, Dr. Li was one of the first scientists to join one of the most successful genomics companies in the U.S., Human Genome Sciences, Inc. where he held positions as Associate Director, Protein Therapeutics, and Group Leader, Drug Target Development.
Dr. Li has been advisor to several Chinese and U.S.
biotechnology companies including Sibiono Biotechnology Company (China) and Abmaxis, Inc and Genpharm, Inc. (SF Bay Area U.S.).
He has served on the Board of Directors of Egen Corporation (San Diego, CA), and Shenzhen Kexing Biotech Co. (Shenzhen, China).
Dr. Li is a former Board member of the Sino-American Pharmaceutical Association (SAPA).
He is also an inventor of thirty five issued US patents.
Dr. Li ranked 3rd place in the CUSBEA Scholarship exam and came to the U.S.
in 1985 as part of the CUSBEA program.
Dr. Li received his Ph.D.
in Biochemistry and Molecular Biology from Harvard University, his M.S.
in Cell Biology from Baylor College of Medicine, and B.S.
in Biochemistry from Nanjing University.
Postes actifs de Yi Li
| Sociétés | Poste | Début |
|---|---|---|
Shanghai Bioveda Investment Management Consulting Co. Ltd.
 Shanghai Bioveda Investment Management Consulting Co. Ltd. Investment ManagersFinance Shanghai Bioveda Investment Management Consulting Co. Ltd. (BioVeda China) is an independent Chinese venture capital firm which was established by Dr. Zhi Yang when BioVeda Capital spun off their China Fund. Headquartered in Shanghai, BioVeda China is the first international life science venture capital firm in China and manages the BioVeda China Fund, backed by blue chip international institutional and corporate investors. The firm's Scientific Advisory Board, comprised of international experts from China and the West, supports BioVeda China by acting as a business and scientific bridge between companies in China and the West, linking finance and technology between the two markets. | Directeur/Membre du Conseil | 01/01/2007 |
NOD Pharmaceuticals, Inc.
 NOD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NOD Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. It focuses on developing oral formulations for insulin, exenatide, interferon, human growth hormone, and more. The company was founded in 2005 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Formation de Yi Li
| Harvard University | Doctorate Degree |
| Baylor College of Medicine | Graduate Degree |
| Nanjing University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Shanghai Bioveda Investment Management Consulting Co. Ltd.
Shanghai Bioveda Investment Management Consulting Co. Ltd. Investment ManagersFinance Shanghai Bioveda Investment Management Consulting Co. Ltd. (BioVeda China) is an independent Chinese venture capital firm which was established by Dr. Zhi Yang when BioVeda Capital spun off their China Fund. Headquartered in Shanghai, BioVeda China is the first international life science venture capital firm in China and manages the BioVeda China Fund, backed by blue chip international institutional and corporate investors. The firm's Scientific Advisory Board, comprised of international experts from China and the West, supports BioVeda China by acting as a business and scientific bridge between companies in China and the West, linking finance and technology between the two markets. | Finance |
NOD Pharmaceuticals, Inc.
NOD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NOD Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. It focuses on developing oral formulations for insulin, exenatide, interferon, human growth hormone, and more. The company was founded in 2005 and is headquartered in San Diego, CA. | Health Technology |
